by journal – Retraction Watch

‘Relieved’: BMJ retracts and replaces article on unexpected weight loss as a sign of cancer

The British Medical Journal has retracted an article examining when unexpected weight loss could be a warning sign of cancer after the authors found an error in their work. The journal published an updated version of the analysis with different conclusions, which the authors think could influence patient care.

The retracted paper, “Prioritising primary care patients with unexpected weight loss for cancer investigation: diagnostic accuracy study,” appeared Aug. 13, 2020. The researchers, led by Brian D. Nicholson, a general practitioner and associate professor in the Nuffield Department of Primary Care Health Sciences at the University of Oxford, England, used electronic health records data to look for people diagnosed with cancer within six months after a recording of unexpected weight loss.

The authors were attempting to replicate their results in another dataset when they found “some differences in the study findings and study population that we could not easily explain,” Nicholson told Retraction Watch. He continued:

eLife won’t get an impact factor, says Clarivate

Clarivate, the data company for scholarly publications, has decided to continue indexing some content from eLife in Web of Science, after reevaluating the open-access biology journal’s unusual practice of publishing articles without accepting or rejecting them. The journal will not receive an Impact Factor.

Last month, Clarivate paused indexing new content from eLife, citing a policy on “Coverage of journals/platforms in which publication is decoupled from validation by peer review.”

eLife last year adopted a new model in which it publishes every manuscript its editors send out for review, along with the text of the reviews and an editor’s assessment of the significance of the findings in the paper and the strength of the evidence presented. The editorial assessments of the paper can be “exceptional,” “compelling,” “convincing,” “solid,” “incomplete,” or “inadequate.”

‘All the red flags’: Scientific Reports retracts paper sleuths called out in open letter

Scientific Reports, a Springer Nature title, has retracted an article a group of sleuths described as “a kind of case study of all the red flags for fraud that we look for” in an open letter to the publisher’s head of research integrity.

The article, “Hybrid CNN-LSTM model with efficient hyperparameter tuning for prediction of Parkinson’s disease,” appeared in September 2023. It has been cited 11 times, according to Clarivate’s Web of Science.

In December 2023, a PubPeer user commented on 13 tortured phrases the Problematic Paper Screener had flagged in the article, such as the use of “Parkinson’s illness,” “Parkinson’s infection,” and “Parkinson’s sickness” rather than Parkinson’s disease.

eLife latest in string of major journals put on hold from Web of Science

Citing eLife’s unusual practice of publishing articles without accepting or rejecting them, Clarivate says it is re-evaluating the inclusion of the open-access biology journal in Web of Science, its influential database of abstracts and citations.

In contrast to the other journals recently placed on hold from indexing, including Elsevier’s Science of the Total Environment, Clarivate has cited a specific policy as the reason for re-evaluating eLife: “Coverage of journals/platforms in which publication is decoupled from validation by peer review.”

A Clarivate spokesperson described the policy as applying to “journals that do not make an editorial decision to accept or reject based on peer reviewers’ comments.”

Cambridge researcher pulls Cell paper five years after Nature, Science retractions

A cancer researcher at the University of Cambridge in the UK has retracted a paper from Cell after commenters on PubPeer questioned aspects of 10 images in the article.

Though an institutional investigation found the figures were “not reliable,” another of the authors objected to the retraction as “an overreaction.”

Steve Jackson, the University of Cambridge biology professor and lab leader, previously retracted two papers – including one in Nature and one in Science posted on the same day – after a Cambridge investigation found a co-author, Abderrahmane Kaidi, had falsified data.

After saying it would retract an article, Cureus changed its mind

Karen Rech, a hematopathologist at Mayo Clinic in Rochester, Minn., was reading a case report about a rare disease when she recognized the patient.

Although the authors of the paper were affiliated with the University of North Dakota School of Medicine and Health Sciences in Fargo, the patient in the report had gone to Mayo for care, and Rech had made the pathology diagnosis. But the article, “A Diagnostic Dilemma and Classification Conundrum: Atypical Histiocytic Neoplasm Presenting as a Calvarial Mass,” published in Cureus in February, didn’t mention or credit Rech or her colleagues.

“The ability to make such a unique diagnosis is a direct result of my translational research in histiocytic neoplasms,” Rech wrote in an email to the journal in April. After she made the pathology diagnosis, a hematologist colleague saw the patient, and a group of specialists discussed the case and came to a consensus diagnosis.

Web of Science puts mega-journals Cureus and Heliyon on hold

Web of Science, Clarivate’s influential database of abstracts and citations, has paused indexation of new content from the open-access journals Heliyon and Cureus, apparently due to concerns about the quality of their articles.

Indexation in WoS or Scopus, another major bibliometric database owned by Elsevier, has become an important stamp of approval for scholarly publications worldwide and can make or break a journal.

WoS is “making a big call here, taking aim at two of the mega-journals that have grown massively in recent years,” said Nick Wise, a scientific sleuth and a researcher at the University of Cambridge in the United Kingdom. “WoS appears to be one of the only organisations with the power to compel big publishers to act. I don’t think that’s a sign of a healthy academic publishing system, but it’s how things are currently.”

Journal retracts article for plagiarized images after trying to gag researcher who complained

The journal Cureus retracted an article for plagiarized images after questioning the motives of the researcher who said her images were taken.

The researcher, who asked to remain anonymous, first emailed Cureus, an open-access journal Springer Nature acquired in 2022, on August 1. She said she noticed images in the October 2023 paper, “Pediatric Acute Dacryocystitis and Orbital Cellulitis With Concurrent COVID-19 Infection: A Case Report,” came from a lecture she posted online and later removed.

“The images used in this article were edited and presented under a fabricated clinical scenario” and had been used without her permission, the researcher wrote in an email seen by Retraction Watch. She requested the journal retract the article. She also provided what she said were her original images, which were replicated in Figure 1 of the paper, and copied the corresponding author of the article.

Paper claiming to discover new pain syndrome retracted

Researchers who said they discovered a new disease akin to rheumatoid arthritis, but caused by pollution, are standing by their claim despite the retraction of their paper last month.

The article, “Middle east pain syndrome is a pollution-induced new disease mimicking rheumatoid arthritis,” appeared in the Springer Nature journal Scientific Reports in November 2021. The paper has been cited once, according to Clarivate’s Web of Science, and received limited press coverage.

According to the retraction notice, “post-publication peer review by an expert has confirmed the validity” of multiple concerns raised about the study. The paper did not present data to support its claims about the presumed cause for the syndrome, didn’t “conclusively” prove that MEPS is a new disease, and the bone erosions the study claimed were a hallmark of the disease weren’t backed by scans, the notice stated. Also, a figure of the paper featured a radiograph of a patient that wasn’t part of the study.

Authors – including a dean and a sleuth – correcting paper with duplicated image

The corresponding author of a paper flagged on PubPeer for an apparently duplicated image will be asking the journal to publish a correction, Retraction Watch has learned.

The paper, “The BET bromodomain inhibitor exerts the most potent synergistic anticancer effects with quinone-containing compounds and anti-microtubule drugs,” appeared in Oncotarget in 2016. Its authors include Marcel Dinger, now a dean at the University of Sydney, who has said he’s working to correct review papers that cited papermill articles, and sleuth Jennifer A. Byrne, also of the University of Sydney.

Earlier this month, an anonymous user on PubPeer pointed out areas of images in figure 6B that were “much more similar than expected.”

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: